Yevgeniy Semenov

24PUBLICATIONS
81CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiologyPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 19, 2026
Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse events.

|Jan 16, 2026
Clinicopathologic and Immunohistochemical Features of Enfortumab Vedotin-Induced Cutaneous Toxicity.

Federico Repetto, Soma Jobbagy, Eudora Lee

|Jul 16, 2025
Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanoma.

Tuulia Vallius, Yingxiao Shi, Edward Novikov

|Jul 16, 2025
Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort study.

Guihong Wan, Nga Nguyen, Charles Lu

|Jun 27, 2025
Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens.

Mei Huang, Dongyao Wang, Jiao Huang

|May 12, 2025
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events.

Sara Khattab, Guihong Wan, Suzanne Xu

Pageof 4

Frequent Collaborators

7 joint publications

Guihong Wan

5 joint publications

Shawn G Kwatra

4 joint publications

Christina M Herbosa

4 joint publications

Shadmehr Demehri